Kyowa Hakko USA Announces the Appointment of Gerard Adams as its New President and CEO

In his new position, Gerard Adams will be responsible for the growth and development of the company.


Gerard Adams, former General Manager, Corporate Strategy, Kyowa Hakko Bio, Tokyo, accepted the position of President and CEO of Kyowa Hakko USA on April 1st, 2022. Now based in the New York City office, Adams takes over from Leo Cullen, who was with KHUS from 2007 to 2022, initially as Vice President of Sales & Marketing, in 2012 as the Executive Vice President, and as President and CEO since January 1st, 2016, until the present.

Since 2009 when Adams joined Kirin Holdings as Senior Director of Corporate Strategy, the two C-Suite executives have worked closely together. Cullen congratulated Adams on this appointment by saying, “Gerard is committed to supporting KHUS during this exciting time, leading with a proven track record of driving growth and innovation. He will spearhead future developments at KHUS, drawing from his wealth of experience in cross-cultural management and high-level strategic corporate planning.”

Stepping into his new role, Adams, who holds Bachelor of Law and Bachelor of Business degrees from the University of Technology, Sydney, Australia, his native country, as well as multiple board positions in both the USA and Japan, is ready for this new chapter of his career. “I’m honored to be taking over from Leo Cullen, who has shown exemplary leadership as CEO. He has not only expanded Kyowa Hakko USA’s business but has built a high functioning team that I’m looking forward to working closely with to grow the business and explore new market opportunities for KHUS.”

As CEO, Adams will be responsible for growing the North & South American sales of Kyowa Hakko USA’s products to its customers in pharmaceutical, dietary supplement, food & beverage, and cosmetics industries, and for all aspects of Kyowa Hakko USA’s business growth and development.

About Kyowa Hakko USA:

Kyowa Hakko USA is the North & South American office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals, and food & beverage products. Kyowa is the maker of branded ingredients including Immuse®; LC-Plasma, Eyemuse®; Lacticaseibacillus paracasei KW3110 Cognizin®; Citicoline, Pantesin®; Pantethine, Setria®; Glutathione, as well as L-Alanyl-L-Glutamine.

« Back